- Stocks
- Healthcare
- NASDAQ: CVET

Price (delayed)

$29.92

Market cap

$4.08B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.22

Enterprise value

$4.85B

Sector: Healthcare

Industry: Health Information Services

The company's equity rose by 23% YoY and by 9% QoQ

The debt has contracted by 10% YoY and by 5% from the previous quarter

Covetrus's EPS has plunged by 100% from the previous quarter but it has soared by 98% YoY

The net income has soared by 98% YoY but it has shrunk by 58% QoQ

CVET's gross margin is down by 2.1% year-on-year

What are the main financial stats of CVET

Market
Valuations
Earnings

Shares outstanding

136.23M

Market cap

$4.08B

Enterprise value

$4.85B

Price to earnings (P/E)

N/A

Price to book (P/B)

2.48

Price to sales (P/S)

0.81

EV/EBIT

231.18

EV/EBITDA

23.01

EV/Sales

1.12

Revenue

$4.34B

EBIT

$21M

EBITDA

$211M

Free cash flow

-$1M

Per share
Balance sheet
Liquidity

EPS

-$0.22

Free cash flow per share

-$0.01

Book value per share

$12.05

Revenue per share

$36.77

TBVPS

$14.86

Total assets

$3.5B

Total liabilities

$1.92B

Debt

$1.07B

Equity

$1.54B

Working capital

$740M

Debt to equity

0.7

Current ratio

2.07

Quick ratio

1.25

Net debt/EBITDA

3.69

Margins
Efficiency
Dividend

EBITDA margin

4.9%

Gross margin

18.4%

Net margin

-0.4%

Operating margin

-1.6%

Return on assets

-0.5%

Return on equity

-1.4%

Return on invested capital

1.1%

Return on capital employed

0.7%

Return on sales

0.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Covetrus stock price performed over time

Intraday

1.6%

1 week

2.43%

1 month

-4.35%

1 year

277.78%

YTD

4.11%

QTD

-0.17%

How have Covetrus's revenue and profit performed over time

Revenue

$4.34B

Gross profit

$798M

Operating income

-$69M

Net income

-$19M

Gross margin

18.4%

Net margin

-0.4%

The net income has soared by 98% YoY but it has shrunk by 58% QoQ

The net margin has soared by 98% YoY but it has contracted by 33% from the previous quarter

Covetrus's operating margin has surged by 94% YoY and by 11% QoQ

CVET's operating income has soared by 93% year-on-year and by 9% since the previous quarter

What is Covetrus's growth rate over time

What is Covetrus stock price valuation

P/E

N/A

P/B

2.48

P/S

0.81

EV/EBIT

231.18

EV/EBITDA

23.01

EV/Sales

1.12

Covetrus's EPS has plunged by 100% from the previous quarter but it has soared by 98% YoY

The P/B is 44% above the last 4 quarters average of 1.7

The company's equity rose by 23% YoY and by 9% QoQ

The P/S is 60% more than the last 4 quarters average of 0.5

Covetrus's revenue has increased by 9% YoY and by 2.7% from the previous quarter

How efficient is Covetrus business performance

The company's return on invested capital has surged by 175% QoQ and by 102% YoY

Covetrus's ROS has soared by 150% from the previous quarter and by 102% YoY

The ROA has soared by 98% YoY but it has plunged by 67% from the previous quarter

The return on equity has surged by 97% year-on-year but it has dropped by 56% since the previous quarter

What is CVET's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CVET.

How did Covetrus financials performed over time

CVET's total assets is 82% greater than its total liabilities

CVET's quick ratio has soared by 67% year-on-year but it is down by 2.3% since the previous quarter

The current ratio has grown by 28% year-on-year

The debt is 30% less than the equity

The debt to equity has declined by 26% year-on-year and by 13% since the previous quarter

The company's equity rose by 23% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.